Conjugated RNAi Therapeutics
A method for modulating at least one pharmacokinetic property of a drug which degrades mRNA upon administration to a host by an siRNA mechanism is provided. In a further embodiment of this invention, a bifunctional compound comprising an siRNA and a recruiter moiety are provided. The recruiter moiet...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
04.06.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A method for modulating at least one pharmacokinetic property of a drug which degrades mRNA upon administration to a host by an siRNA mechanism is provided. In a further embodiment of this invention, a bifunctional compound comprising an siRNA and a recruiter moiety are provided. The recruiter moiety may be lipophilic and may enable the siRNA to cross cell membranes and then targets an endogenous, intracellular protein to allow better distribution of the therapeutic into the cell and therefore, higher efficacy. |
---|---|
Bibliography: | Application Number: US20080191940 |